The Day’s Play Edition 81: ASX licensing deals, graphite processing JVs and reserve growth updates | Recce secures MENA pathway, IG6 signs European processing JV, Ariana lifts Dokwe reserves 42%
THE COIN TOSS
RCE – Recce Pharmaceuticals secured a 10 year exclusive MENA licensing pathway for R327G with potential milestone payments up to USD$3.5M.
IG6 – International Graphite signed a binding JV establishing a European graphite processing platform targeting 10,000t/y initial capacity.
AA2 – Ariana Resources lifted Dokwe Ore Reserves 42% to 1.13Moz as revised PFS increased pre tax NPV10 to US$1,056M.
LU7 – Lithium Universe secured exclusive global rights to commercialise e waste technology recovering gold and copper.
MRR – Minrex Resources fully funded ~7,000m drilling targeting Barje resource conversion and advancing Tlamino toward development studies.
BGD – Barton Gold extended higher grade Area 51 mineralisation beyond pit limits as Tunkillia drilling expanded resource growth potential.
CRS – Caprice Resources expanded the Island gold system with new high grade intercepts beyond the Vadrians trend.
SVY – Stavely Minerals advanced Thursday’s Gossan development pathway after optimisation work captured most of the 60Mt resource.
WC1 – West Cobar Metals achieved up to 81% scandium recovery supporting lower cost processing pathways.
YUG – Yugo Metals confirmed a new Erak gold system after every maiden drillhole intersected mineralised alteration.
AM5 – Antares Metals confirmed district scale high grade gold at Quinns and advanced 3 targets toward maiden drilling.
Recce Pharmaceuticals (ASX:RCE)
Exclusive MENA Licensing Term Sheet Advances Commercial Pathway
|
|
THE PLAY
THE PITCH
- R327G targets Diabetic Foot Infections across high burden diabetes regions
- Proposed licensing territory spans Saudi Arabia, GCC countries and North Africa
- Recce retains responsibility for manufacturing and supplying R327G treatments
- Registrational Phase 3 DFI trial continues enrolling patients in Indonesia
- Licensee operates across more than 30 international pharmaceutical markets
THE NEXT OVERS
- Parties aim to finalise definitive licensing agreement next quarter
- Ongoing negotiations and due diligence precede final agreement execution
- Ongoing Phase 3 trial data intended for KSA regulatory submission
Read full ASX Announcement here.
|
|
|
|
International Graphite (ASX:IG6)
Binding JV Establishes European Graphite Processing Platform
|
|
|
|
|
|
Ariana Resources (ASX:AA2)
Dokwe PFS Lifts Reserves And Project Economics
|
|
|
|

Lithium Universe (ASX:LU7)
Global Licence Secured For E Waste Metal Recovery
|
|
|
|
|
|
Minrex Resources (ASX:MRR)
Tlamino Drilling Resets Barje Development Path
|
|
|
|
|
|
Barton Gold (ASX:BGD)
Higher Grade Area 51 Drilling Expands Pit Scale
|
|
|
|

Caprice Resources (ASX:CRS)
High Grade Gold Extends Beyond Vadrians Trend
|
|
|
|
—————
Stavely Minerals (ASX:SVY)
Open Pit Optimisations Reshape Thursday’s Gossan Development
|
|
|
|
|
|
West Cobar Metals (ASX:WC1)
Scandium Recoveries Support Lower Cost Development Pathway
|
|
|
|

Yugo Metals (ASX:YUG)
Every Maiden Erak Hole Intersects Gold System
|
|
|
|
|
|
Antares Metals (ASX:AM5)
Multiple High Grade Gold Targets Emerge At Quinns
|
|
|
|